I have only been a member of Motley Fool for almost 1 year but in over 300 stock recommendations by The Fool, I cannot believe that Eli Lilly was not one of them. It has skyrocketed over its 2022 price based on obesity and alzheimers drugs. I have made the most money of any of my stocks with Eli Lilly and it was not a recommendation of the Fool. How can they be so blind to this powerhouse in the pharmaceutical category?
5 Likes
You might have better luck with the question if you ask in the Premium Community, where you have access as a subscriber. Not everyone here on the free side has a subscription so they don’t know what has or has not been recommended.
Thanks. I reposted it